| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
10,590,000 |
| Market
Cap: |
2.12(K) |
| Last
Volume: |
13,822,625 |
Avg
Vol: |
11,133,964 |
| 52
Week Range: |
$0.0002 - $0.05695 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Viveve Medical is a holding company. Through its subsidiaries, Co. designs, develops, manufactures and markets a platform medical technology, which it refers to as Cryogen-cooled Monopolar Radiofrequency (CMRF). Co.'s proprietary CMRF technology is delivered through a radiofrequency generator, handpiece and treatment tip, that collectively, Co. refers to as the Viveve® System. The Viveve System is for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence depending on the relevant country-specific clearance or approval, that Co. refers to as the Viveve treatment.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Basta Steven L |
Director |
• • – |
2021-12-15 |
4 |
D |
$1.41 |
$39 |
D/D |
(28) |
25 |
|
- |
|
| Robbins Jim B |
SVP, Finance & Administration |
• • – |
2021-12-15 |
4 |
D |
$1.43 |
$51 |
D/D |
(36) |
0 |
|
- |
|
| Durbin Scott |
Chief Executive Officer |
• • – |
2021-12-15 |
4 |
D |
$1.40 |
$3 |
D/D |
(2) |
10 |
|
- |
|
| Goldman Sachs & Co |
None - See FN 3 |
– – – |
2019-10-01 |
4/A |
S |
$5.56 |
$131,711 |
I/I |
(23,688) |
0 |
|
- |
|
| Goldman Sachs & Co |
|
– – • |
2019-10-01 |
4/A |
S |
$5.56 |
$131,711 |
I/I |
(23,688) |
0 |
|
- |
|
| Goldman Sachs & Co |
|
– – • |
2019-10-01 |
4 |
S |
$5.56 |
$131,705 |
I/I |
(23,688) |
0 |
|
- |
|
| Goldman Sachs & Co |
|
– – • |
2019-10-01 |
4 |
S |
$5.56 |
$131,705 |
I/I |
(23,688) |
0 |
|
- |
|
| Goldman Sachs & Co |
None - See FN 3 |
– – – |
2019-09-30 |
4/A |
S |
$4.55 |
$312,753 |
I/I |
(68,737) |
23,688 |
|
- |
|
| Goldman Sachs & Co |
|
– – • |
2019-09-30 |
4/A |
S |
$4.55 |
$312,753 |
I/I |
(68,737) |
23,688 |
|
- |
|
| Goldman Sachs & Co |
|
– – • |
2019-09-30 |
4 |
S |
$4.55 |
$312,753 |
I/I |
(68,737) |
23,688 |
|
- |
|
| Goldman Sachs & Co |
|
– – • |
2019-09-30 |
4 |
S |
$4.55 |
$312,753 |
I/I |
(68,737) |
23,688 |
|
- |
|
| Goldman Sachs & Co |
None - See FN 3 |
– – – |
2019-09-27 |
4/A |
S |
$5.10 |
$27,331 |
I/I |
(5,359) |
92,425 |
|
- |
|
| Goldman Sachs & Co |
|
– – • |
2019-09-27 |
4/A |
S |
$5.10 |
$27,331 |
I/I |
(5,359) |
92,425 |
|
- |
|
| Goldman Sachs & Co |
|
– – • |
2019-09-27 |
4 |
S |
$5.02 |
$26,902 |
I/I |
(5,359) |
92,425 |
|
- |
|
| Goldman Sachs & Co |
|
– – • |
2019-09-27 |
4 |
S |
$5.02 |
$26,902 |
I/I |
(5,359) |
92,425 |
|
- |
|
| Goldman Sachs & Co |
None - See FN 3 |
– – – |
2019-09-26 |
4/A |
S |
$5.25 |
$36,755 |
I/I |
(7,001) |
97,784 |
|
- |
|
| Goldman Sachs & Co |
|
– – • |
2019-09-26 |
4/A |
S |
$5.25 |
$36,755 |
I/I |
(7,001) |
97,784 |
|
- |
|
| Goldman Sachs & Co |
|
– – • |
2019-09-26 |
4 |
S |
$5.25 |
$36,755 |
I/I |
(7,001) |
97,784 |
|
- |
|
| Goldman Sachs & Co |
|
– – • |
2019-09-26 |
4 |
S |
$5.25 |
$36,755 |
I/I |
(7,001) |
97,784 |
|
- |
|
| Goldman Sachs & Co |
None - See FN 3 |
– – – |
2019-09-25 |
4/A |
S |
$5.62 |
$60,690 |
I/I |
(10,799) |
104,785 |
|
- |
|
| Goldman Sachs & Co |
|
– – • |
2019-09-25 |
4/A |
S |
$5.62 |
$60,690 |
I/I |
(10,799) |
104,785 |
|
- |
|
| Goldman Sachs & Co |
|
– – • |
2019-09-25 |
4 |
S |
$5.63 |
$60,798 |
I/I |
(10,799) |
104,785 |
|
- |
|
| Goldman Sachs & Co |
|
– – • |
2019-09-25 |
4 |
S |
$5.63 |
$60,798 |
I/I |
(10,799) |
104,785 |
|
- |
|
| Goldman Sachs & Co |
None - See FN 3 |
– – – |
2019-09-24 |
4/A |
S |
$5.57 |
$4,456 |
I/I |
(800) |
115,584 |
|
- |
|
| Goldman Sachs & Co |
None - See FN 3 |
– – – |
2019-09-24 |
4/A |
B |
$5.64 |
$147,768 |
I/I |
26,200 |
116,384 |
0.01 |
- |
|
165 Records found
|
|
Page 1 of 7 |
|
|
